Menu
Search
|

Menu

Close
X

Aevi Genomic Medicine Inc GNMX.OQ (NASDAQ Stock Exchange Global Market)

1.80 USD
-0.30 (-14.29%)
As of 8:59 PM GMT
chart
Previous Close 2.10
Open 2.13
Volume 85,314
3m Avg Volume 69,511
Today’s High 2.13
Today’s Low 1.80
52 Week High 6.17
52 Week Low 0.98
Shares Outstanding (mil) 37.11
Market Capitalization (mil) 52.33
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
0
FY15
0
EPS (USD)
FY17
-0.511
FY16
-1.202
FY15
-1.464
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.90
Price to Sales (TTM)
vs sector
--
5.77
Price to Book (MRQ)
vs sector
2.94
5.41
Price to Cash Flow (TTM)
vs sector
--
23.42
Total Debt to Equity (MRQ)
vs sector
0.00
16.52
LT Debt to Equity (MRQ)
vs sector
0.00
12.22
Return on Investment (TTM)
vs sector
-109.84
14.43
Return on Equity (TTM)
vs sector
-109.84
16.13

EXECUTIVE LEADERSHIP

Sol Barer
Non-Executive Chairman of the Board, Since 2012
Salary: --
Bonus: --
Michael Cola
President, Chief Executive Officer, Director, Since 2013
Salary: $450,000.00
Bonus: $299,250.00
Brian Piper
Chief Financial Officer, Corporate Secretary, Since 2016
Salary: $290,985.00
Bonus: $139,673.00
Garry Neil
Chief Scientific Officer, Since 2013
Salary: $410,000.00
Bonus: $236,160.00
Matthew Bayley
Director, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

435 Devon Park Dr Ste 715
WAYNE   PA   19087-1946

Phone: +1610.2544201

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .

SPONSORED STORIES